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In inﬂammation, inducible nitric oxide synthase (iNOS) produces nitric oxide (NO), which modulates inﬂammatory processes.
We investigated the eﬀects of Janus kinase (JAK) inhibitors, AG-490 and WHI-P154, on iNOS expression and NO production in
J774 murine macrophages stimulated with interferon-γ (IFN-γ). JAK inhibitors AG-490 and WHI-P154 decreased IFN-γ-induced
nuclear levels of signal transducer and activator of transcription 1α (STAT1α). JAK inhibitors AG-490 and WHI-P154 decreased
also iNOS protein and mRNA expression and NO production in a concentration-dependent manner. Neither of the JAK inhibitors
aﬀected the decay of iNOS mRNA when determined by actinomycin D assay. Our results suggest that the inhibition of JAK-
STAT1-pathway by AG-490 or WHI-P154 leads to the attenuation of iNOS expression and NO production in IFN-γ-stimulated
macrophages.
Copyright © 2006 Outi Sareila et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Nitric oxide (NO) is a small gaseous signalling molecule that
is synthesized from amino acid L-arginine in a reaction cat-
alyzed by nitric oxide synthase (NOS). In mammalian cells,
there are three isoforms of the enzyme: neuronal nNOS and
endothelial eNOS are constitutively expressed and the third
isoform, iNOS, is induced in response to proinﬂammatory
cytokines and bacterial products in inﬂammatory and tis-
sue cells [4, 8, 13]. Once iNOS is expressed, it produces
high amounts of NO for prolonged periods. NO produc-
tion through iNOS pathway is regulated mainly at the level
of iNOS expression [8, 10] .I ni n ﬂ a m m a t i o n ,N Om o d u l a t e s
immuneresponsesandinﬂammatoryprocess[10,16],andis
associatedwiththepathophysiologyofvariousinﬂammatory
diseases such as asthma [18] and arthritis [23]. Compounds
that inhibit iNOS expression or iNOS activity have a promise
as antiinﬂammatory drugs based on their eﬀects in various
forms of experimentally-induced inﬂammation [22].
One of the central cytokines involved in the induction
of iNOS expression and NO production in macrophages is
interferon-γ (IFN-γ). IFN-γ regulates iNOS expression at
transcriptional and post-transcriptional level [8, 10]. One
of the intracellular signal transduction pathways that are
activated by IFN-γ is Janus kinase (JAK)—signal trans-
ducer and activator of transcription (STAT) -pathway [17].
In the present study, we investigated the eﬀects of two
JAK inhibitors, AG-490 and WHI-P154, on the IFN-γ-
induced iNOS expression and NO production in cultured
macrophages. Both compounds inhibited iNOS expression
a n dN Op r o d u c t i o ni nI F N - γ-treated macrophages along
with their inhibitory eﬀe c to na c t i v a t i o no fS T A T 1 .
MATERIALS AND METHODS
Materials
JAK inhibitors AG-490 (tyrphostin B42) and WHI-P154
(Calbiochem, La Jolla, Calif, USA), rabbit polyclonal mouse
iNOS and STAT1α p91 antibodies and goat anti-rabbit HRP-
conjugated polyclonal antibody (Santa Cruz Biotechnology,
Santa Cruz, Calif, USA), rabbit polyclonal phospho-STAT1
(Tyr701) antibody (Cell Signaling Technology Inc, Beverly,
Mass, USA) and recombinant mouse γ-interferon (R&D sys-
tems, Minneapolis, Minn, USA) were obtained as indicated.
All other reagents were from Sigma Chemical Co (St Louis,
Mo, USA).2 Mediators of Inﬂammation
Cellculture
J774 macrophages (ATCC, Manassas, Virginia, USA) were
cultured at 37◦Ci n5 %C O 2 atmosphere in Dulbecco’s
modiﬁed Eagle’s medium with Glutamax-I (Cambrex Bio-
Science, Verviers, Belgium) containing 10% heat-inactivated
fetal bovine serum (Cambrex BioScience), 100U/mL peni-
cillin,100μg/mLstreptomycin,and250ng/mLamphotericin
B (all from Gibco, Paisley, UK). Cells were seeded on 24-
well plates for nitrite measurement and RT-PCR, on 6-well
plates for Western blot and on 10cm dishes for nuclear ex-
tract preparation, and were grown for 72h to conﬂuence be-
fore the commencement of the experiments.
Toxicity of the tested compounds was ruled out by mea-
suring cell viability using Cell Proliferation Kit II (XTT)
(Roche Diagnostics GmbH, Mannheim, Germany) accord-
ing to the manufacturer’s instructions.
Preparationofcelllysates
At indicated time points, cells were rapidly washed with
ice-cold phosphate-buﬀered saline (PBS) containing 2mM
sodiumorthovanadate. For pSTAT1 Western blot, the cells
were solubilized in cold lysis buﬀer (1% NP-40, 150mM
NaCl,50mMTrispH7.5,1mMEDTA,1mMphenylmethyl-
sulfonylﬂuoride, 2mM sodiumorthovanadate, 80μMl e u -
peptin, 1μg/mL aprotinin, 1mM NaF, 1μg/mL pepstatin,
2mM sodiumpyrophosphate, 0.25% sodiumdeoxycholate
and 10μM N-octyl-β-D-glucopyranoside). After incubation
for 15min on ice, lysates were centrifuged (13 500g, 5min).
Theproteincontentofthesupernatantswasmeasuredbythe
Coomassie blue method.
For iNOS Western blot, the cells were resuspended in
lysis buﬀer containing 1% Triton X, 50mM NaCl, 10mM
Tris-base pH 7.4, 5mM EDTA, 0.5mM phenylmethyl-
sulfonylﬂuoride, 1mM sodiumorthovanadate, 40μMl e u -
peptin, 50μg/mL aprotinin, 5mM NaF, 2mM sodiumpy-
rophosphate, 10μM N-octyl-β-D-glucopyranoside. Other-
wise the lysis was performed as described above.
Preparationofnuclearextracts
At indicated time points, the cells were rapidly washed
with ice-cold PBS and solubilized in hypotonic buﬀer A
(10mM HEPES-KOH pH 7.9, 1.5mM MgCl2,1 0m MK C l ,
0.5mM dithiotreitol, 0.2mM phenylmethylsulfonylﬂuoride,
10μg/mL leupeptin, 25μg/mL aprotinin, 0.1mM EGTA,
1mM sodiumorthovanadate, 1mM NaF). After incubation
for 10min on ice, the cells were vortexed for 30s and the
nuclei separated by centrifugation at 4◦C, 21 000g for 10s.
The pellet was resuspended in buﬀer C (20mM HEPES-
KOH pH 7.9, 420mM NaCl, 25% glycerol, 1.5mM MgCl2,
0.2mM EDTA, 0.5mM dithiotreitol, 0.2mM phenylmethyl-
sulfonylﬂuoride, 10μg/mL leupeptin, 25μg/mL aprotinin,
0.1mM EGTA, 1mM sodiumorthovanadate, 1mM NaF)
and incubated on ice for 20min. Nuclei were vortexed for
30s and nuclear extracts were obtained by centrifugation at
4◦C, 21 000g for 2min. The protein content of the super-
natant was measured by the Coomassie blue method. The
samples were boiled in SDS sample buﬀer and stored at
−20◦C.
Westernblotting
Protein (20μg of lysates or nuclear extracts) was loaded on
8% SDS-polyacrylamide electrophoresis gel and was elec-
trophoresed for 2h at 120V in buﬀer containing 25mM Tris
base, 250mM glycine and 0.1% SDS. After electrophoresis,
the proteins were electrically transferred to Hybond ECLTM
nitrocellulose membrane (Amersham Biosciences UK, Ltd.,
Little Chalfont, Buckinghamshire, UK) in buﬀer containing
25mM Tris, 192mM glycine, 20% methanol, and 0.005%
SDS. After transfer, the membrane was blocked in TBST
(20mM Tris base pH 7.6, 150mM NaCl, 0.1% Tween-20)
containing 5% skimmed milk for 1h at room temperature.
The membrane was incubated with anti-STAT1α or anti-
iNOS in the blocking solution for 1h at room tempera-
ture or with anti-pSTAT1 in TBST containing 5% bovine
serum albumin at 4◦C overnight. Thereafter the membrane
was washed three times with TBST for 5min, incubated
with secondary antibody in the blocking solution for 50min
at room temperature, and washed three times with TBST
for 5min. Bound antibody was detected using Super Sig-
nal West Pico or Dura chemiluminescent substrate (Pierce,
R o c k f o r d ,I l l ,U S A )a n dF l u o r C h e m TM 8800 imaging sys-
tem(AlphaInnotechCorporation,SanLeandro,Calif,USA).
The quantitation of the chemiluminescent signal was car-
ried out with the use of FluorChemTM software version
3.1.
RNAextractionsandquantitativePCR
Cell homogenization, RNA extraction, reverse transcription,
and quantitative PCR were performed as described in [11].
Mouse iNOS and glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) primers and probes [6-FAM (6-carboxy-
ﬂuorescein) as 5 -reporter dye and TAMRA (6-carboxy-
tetramethyl-rhodamine) as 3 -quencher] were designed us-
ing Express Software (Applied Biosystems, Foster City, Calif,
USA) and were 5 -CCTGGTACGGGCATTGCT-3  (mi-
NOS forward), 5 -GCTCATGCGGCCTCCTT-3  (miNOS
reverse), 5 -CAGCAGCGGCTCCATGACTCCC-3  (miNOS
probe), 5 -GCATGGCCTTCCGTGTTC-3  (GAPDH for-
ward), 5 -GATGTCATCATACTTGGCAGGTTT-3  (GAPDH
reverse), and 5 -TCGTGGATCTGACGTGCCGCC-3  (the
GAPDH probe). The primers were used at 300nM and the
probes at 150nM concentrations. All primers and probes
were purchased from Metabion Planegg-Martinsried, Ger-
many. Thermal cycling conditions were: incubation at 50◦C
for 2min, 95◦C for 10min, thereafter 40 cycles of denatu-
ration at 92◦C for 15s, and annealing/extension at 60◦Cf o r
1min. The relative mRNA levels were quantiﬁed and com-
pared using the relative standard curve method as described
in Applied Biosystems User Bulletin #2. Each sample was de-
termined in duplicate.Outi Sareila et al 3
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Figure1:(a)Time-dependentactivation(Tyr701phosphorylation)
of signal transducer and activator of transcription 1 (STAT1) by
interferon-γ (IFN-γ) in J774 macrophages. Cells were treated with
IFN-γ (5ng/mL) for diﬀerent times as indicated. Proteins were ex-
tracted with modiﬁed RIPA-buﬀer, and the protein contents were
measured. Equal amounts of lysates (20μg protein) were subjected
to immunoblot analysis with antibody speciﬁc for STAT1 phospho-
rylated at the tyrosine residue 701. Similar results were obtained
in three independent experiments. (b) Time-dependent nuclear
translocation of STAT1α in IFN-γ-stimulated J774 macrophages.
Cells were treated with IFN-γ (5ng/mL) for diﬀerent times as in-
dicated. The nuclear proteins were extracted as described in mate-
rials and methods. The protein content of the samples was mea-
sured, and equal amounts of proteins (20μg) were subjected to im-
munoblot analysis with antibody against STAT1α. Similar results
were obtained in two independent experiments.
Nitriteassays
After 24h incubation, the culture medium was collected for
the nitrite measurement, which was used as a measure of NO
production. Culture medium (100μL) was incubated with
100μL of Griess reagent (0.1% napthalethylenediamine di-
hydrochloride, 1% sulfanilamine, 2.4% H3PO4) and the ab-
sorbance was measured at 540nm. The concentration of ni-
trite was calculated with sodium nitrite as a standard [5].
Statistics
Results are expressed as mean ± standard error of mean
(SEM). When indicated, statistical analysis was carried out
by analysis of variances supported by Dunnett adjusted sig-
niﬁcance levels. Diﬀerences were considered signiﬁcant at
P<. 05.
RESULTS
ActivationofSTAT1byIFN-γ
Activation of the JAK-STAT signalling pathway in J774
mouse macrophages was studied by measuring STAT1
phosphorylation and nuclear translocation of STAT1α af-
ter IFN-γ-treatment. In cells treated with IFN-γ, tyrosine
(Tyr701) phosphorylation of STAT1 was detected 15min af-
ter addition of IFN-γ and it was further enhanced up to 60
minutes (Figure 1(a)). Phosphorylated STATs dimerize and
diﬀuse into the nucleus to initiate transcription [6]. There-
fore we investigated the nuclear translocation of STAT1α
in IFN-γ-stimulated J774 macrophages. The presence of
STAT1α in nuclear extracts was measured by Western blot.
The level of STAT1α in the nucleus increased in a time-
dependent manner after addition of IFN-γ into the culture.
In nuclei, low levels of STAT1α were detected already 5min
afterexposuretoIFN-γ anditwasincreasedupto30minutes
(Figure 1(b)).
EffectsofJAKinhibitorsAG-490andWHI-P154on
STAT1activation
The action of JAK inhibitors AG-490 and WHI-P154 on
STAT1 activation was studied by measuring their eﬀects on
nuclear translocation of STAT1α in IFN-γ-stimulated cells.
Both AG-490 and WHI-P154 decreased the nuclear translo-
cation of STAT1α in a concentration-dependent manner
(Figure 2). WHI-P154 was somewhat more potent than AG-
490, and at 10μM drug concentration, WHI-P154 decreased
the IFN-γ-induced nuclear translocation of STAT1α by ap-
proximately 50% when measured after 30min incubation
with IFN-γ.
EffectsofJAKinhibitorsAG-490andWHI-P154on
NOproductioninJ774macrophages
To investigate the eﬀects of JAK inhibitors on NO produc-
tion in J774 macrophages, the cells were treated with IFN-γ
in the absence or in the presence of increasing concentra-
tions (3, 10, and 30μM) of JAK inhibitors AG-490 and WHI-
P154, and NO production was detected as nitrite accumula-
tion in the culture medium. IFN-γ induced NO production
in J774 macrophages and it was inhibited in a concentration-
dependent manner by AG-490 and WHI-P154 (Figure 3).
WHI-P154 was somewhat more potent inhibitor of NO pro-
duction than AG-490. Cytotoxicity as a contributing factor
wasruledoutbyXTTtest.Whenthecompoundswereadded
to cells 6h after IFN-γ stimulation, no eﬀect on NO produc-
tion was seen. This suggests that the compounds do not in-
hibit iNOS activity but rather suppress iNOS expression.
EffectsofJAKinhibitorsAG-490andWHI-P154on
iNOSproteinexpression
The eﬀects of JAK inhibitors, AG-490 and WHI-P154,
on iNOS protein expression were investigated by Western
blot analysis. IFN-γ induced iNOS protein expression in
J774 macrophages, and it was reduced in a concentration-
dependent manner by AG-490 or WHI-P154 (Figure 4).
EffectsofJAKinhibitorsAG-490andWHI-P154on
iNOSmRNAexpressionanddecay
The eﬀects of JAK inhibitors, AG-490 and WHI-P154, on
iNOS mRNA expression in IFN-γ treated cells were mea-
sured by quantitative PCR. Both AG-490 (10μM) and
WHI-P154 (10μM) reduced iNOS mRNA levels by 60%4 Mediators of Inﬂammation
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Figure 2: Eﬀects of AG-490 and WHI-P154 on nuclear translocation of STAT1α in IFN-γ-stimulated J774 macrophages. The cells were
pretreated with (a) AG-490 or (b) WHI-P154 for 30 minutes. Thereafter, the medium was replaced with fresh medium containing the
combination of the inhibitor and IFN-γ (5ng/mL). The cells were incubated for another 30minutes, and the nuclear proteins were extracted
as described in materials and methods. The protein content of the samples was measured and equal amounts (20μg) were subjected to
immunoblot analysis with antibody against STAT1α. The results are expressed as mean ± SEM (n = 2–3 for AG-490 and n = 4f o rW H I -
P154).
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Figure 3: Eﬀects of (a) AG-490 and (b) WHI-P154 on IFN-γ-induced nitric oxide (NO) generation in J774 macrophages. After 24-hour
incubation with IFN-γ (5ng/mL), the supernatants were collected and nitrite was measured in the culture medium as an indicator of NO
production by Griess reaction. The values are mean ± SEM (n = 6), ∗P<. 05, and ∗∗P<. 01 when compared to cells treated with IFN-γ
alone.Outi Sareila et al 5
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Figure 4: Eﬀects of (a) AG-490 and (b) WHI-P154 on iNOS protein expression in J774 macrophages. Cells were incubated with IFN-γ
(5ng/mL) in the presence or in the absence of the tested compound for 24hours. Cells were lysed and the protein content of the lysates was
measured, and equal amounts of proteins (20μg) were subjected to immunoblot analysis with an antibody against iNOS. The results are
shown as mean ± SEM (n = 6 for AG-490 and n = 4 for WHI-P154), ∗∗P<. 01 when compared to cells treated with IFN-γ alone.
when measured after 4h incubation (Figure 5(a)). To study
whether the JAK inhibitors aﬀect the rate of iNOS mRNA
degradation, actinomycin D assay was applied. An inhibitor
of transcription, actinomycin D (0.1μg/mL), was added into
the culture after 6h incubation with IFN-γ or a combina-
tion of IFN-γ and the drugs tested. Cells were harvested at
time points 0, 1, 2, 3, 4, and 6h after the addition of actino-
mycin D. Neither AG-490 nor WHI-P154 aﬀected the decay
of iNOS mRNA (Figure ). The results suggest that AG-490
andWHI-P154suppressiNOSexpressionattheleveloftran-
scription rather than at the level of regulation of the stability
of iNOS mRNA.
DISCUSSION
In the present study, we tested the eﬀects of two JAK in-
hibitors, AG-490 and WHI-P154, on the activation of JAK-
STAT1-signalling pathway, iNOS expression, and NO pro-
d u c t i o ni nI F N - γ-treated macrophages. JAK inhibitors AG-
490 and WHI-P154 decreased IFN-γ-induced iNOS expres-
sionandNOproductionalongwithinhibitionofSTAT1acti-
vation. To our knowledge, down-regulation of iNOS expres-
sionandNOproductionbyJAKinhibitorWHI-P154hasnot
been reported previously. The inhibitors did not aﬀect the
decay of iNOS mRNA.
Typically, cytokine stimulation involves the ligation of
two diﬀerent receptor subunits, and this results in the for-
mation of JAK heterodimers and their subsequent autophos-
phorylation. IFN-γ signalling preferentially leads to activa-
tionofSTAT1[6],whichisphosphorylatedonTyr701byJAK
[12]. Phosphorylation of STAT1 induces STAT1 dimeriza-
tion, nuclear translocation, and initiation of transcription of
gamma activated site (GAS) -driven genes [7]. In our study,
we followed STAT1 activation by detecting STAT1 (Tyr701)
phosphorylation and by probing nuclear lysates for STAT1α
at diﬀerent time points after IFN-γ activation. The results
show that STAT1 was activated in 15 minutes after IFN-γ-
stimulation in J774 cells. Similar results have been reported
recentlywhenwholecellandnuclearlysatesofJ774cellswere
immunoblotted for phosphorylated STAT1 [3].
STAT1hasbeenreportedtoactasakeytranscriptionfac-
torinIFN-γ-dependentmouseiNOSexpression[1],whereas
NF-κB, another important transcription factor in the induc-
tionofiNOS,ismerelyinvolvedinlipopolysaccharide(LPS)-
induced iNOS expression and has a minor role following
IFN-γ stimulation [1, 24]. An IFN-γ-activated site (GAS) is
necessary for full expression of iNOS in response to IFN-
γ and LPS [2, 15]. In addition, macrophages derived from
STAT1-deﬁcient mice displayed severely impaired NO pro-
duction in response to a combination of IFN-γ andLPS[15].
In the present study, stimulation of J774 macrophages by
IFN-γ led to the phosphorylation and nuclear translocation
of STAT1, which was inhibited by AG-490 and WHI-P154.
On molar basis, WHI-P154 was somewhat more potent in-
hibitor than AG-490. Similarly to our results, AG-490 has
previouslybeenshowntopreventJAK2phosphorylationand
to decrease STAT1 phosphorylation in J774 cells [1]a n dt o
decrease activation of STAT1 pathway in B-cell chronic lym-
phocytic leukemia (B-CLL) cells [14]. WHI-P154 was de-
signed to speciﬁcally inhibit JAK3, and it has been shown
to inhibit IL-2-triggered JAK3-dependent STAT activation in
32Dc11-IL-2Rβ-cells [20]. WHI-P131 (another WHI-P154-
related JAK inhibitor) has been shown to inhibit STAT1 acti-
vation in B-CLL cells, in platelets, and in mesenchymal stem6 Mediators of Inﬂammation
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Figure 5: Eﬀects of JAK inhibitors, AG-490 and WHI-P154, on IFN-γ-induced iNOS mRNA expression and degradation in J774
macrophages. (a) Cells were incubated with IFN-γ (5ng/mL) in the absence or in the presence of AG-490 and WHI-P154 (10μM). The
cells were disrupted after 4-hour incubation and total RNA was collected. Isolated RNA was converted to cDNA. iNOS and GAPDH mRNAs
were measured by quantitative PCR, and iNOS mRNA levels were normalized against GAPDH mRNA. The results are expressed as mean
± SEM, n = 3. ∗∗P<. 01 when compared to cells treated with IFN-γ alone. (b) Cells were incubated as in (a) except that actinomycin D
(actD) (0.1μg/mL) was added after 6-hour incubation to stop transcription. Incubations were terminated at the indicated time points after
addition of actD into the culture medium. Total RNA was isolated and converted to cDNA. iNOS and GAPDH mRNA were measured by
quantitative PCR. iNOS mRNA levels were normalized against GAPDH mRNA. The results are expressed as mean ± SEM, n = 3.
cells [14, 19, 21]. Here we extend the earlier data by show-
ing that WHI-P154 inhibits STAT1 activation also in IFN-γ-
treated macrophages.
Inthepresentstudy,IFN-γ inducediNOSexpressionand
NO production in J774 macrophages, and it was inhibited by
JAK inhibitors, AG-490 andWHI-P154, inadose-dependent
manner along with their inhibitory action on STAT1 acti-
vation. When the drugs were added to the culture 6h after
IFN-γ,n oe ﬀect on NO production was detected suggest-
ing that the compounds do not inhibit iNOS activity. The
results conﬁrm the earlier studies showing that AG-490 in-
hibits IFN-γ-induced iNOS expression in macrophages [1].
To our knowledge, down-regulation of iNOS expression and
NO production by JAK inhibitor WHI-P154 has not been re-
ported previously.
The regulation of iNOS expression is controlled at the
levelofmRNAstabilityinadditiontothetranscriptionalreg-
ulation[8,10].Inmurinemacrophages,dexamethasone,and
SP600125, an inhibitor of c-Jun N-terminal kinase (JNK),
reduced LPS-induced iNOS expression by destabilizing the
mRNA [9, 11]. In contrast, IFN-γ has been shown to re-
tard iNOS mRNA degradation when compared to iNOS
mRNAinducedbyLPSalone[9].Inthepresentstudy,theef-
fects of AG-490 and WHI-P154 on iNOS mRNA decay were
tested by actinomycin D assay. JAK inhibitors, AG-490 and
WHI-P154 did not aﬀect the rate of degradation of iNOS
mRNA in cellstreatedwith IFN-γ. This suggeststhat AG-490
and WHI-P154 inhibit iNOS expression at transcriptional
level and they do not regulate mechanisms involved in the
iNOS mRNA stabilization.
In conclusion, we have shown that JAK inhibitors,
AG-490 and WHI-P154 down-regulate STAT1 activa-
tion, iNOS expression, and NO production in IFN-γ-
treated macrophages. A better understanding of the mech-
anisms regulating iNOS expression and NO produc-
tion in inﬂammation could facilitate the development of
novel anti-inﬂammatory drugs acting through iNOS path-
way.
ABBREVIATIONS
AG-490, α-cyano-(3,4-dihydroxy)-N-benzylcinnamide; B-
CLL, B-cell chronic lymphocytic leukemia; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; GAS, gamma
activated site; IFN, interferon; IL, interleukin; iNOS, in-
ducible nitric oxide synthase; JAK, Janus kinase; JNK, c-Jun
N-terminal kinase; LPS, lipopolysaccharide; NO, nitric
oxide; STAT, signal transducer and activator of transcription;
WHI-P154, 4-(3 -bromo-4 -hydroxylphenyl)-amino-6,7-di-
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